Completed Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease NCT03065192 Conditions Basal Ganglia Disease, Basal Ganglia Diseases, Brain Diseases, +9 more Locations University of California, San Francisco (UCSF) — San Francisco, California, United States Emory University — Atlanta, Georgia, United States Ohio State University (OSU) — Columbus, Ohio, United States University of Pittsburgh Medical Center (UPMC) — Pittsburgh, Pennsylvania, United States View Trial Details
